Advertisement

Information on global poultry, pig and animal feed markets.
Industry News & Trends
on February 16, 2017

Boehringer Ingelheim accepting proposals for European PRRS Research Award

The animal health company will fund three research projects for improved control of the swine disease PRRS

For the fourth time, Boehringer Ingelheim Animal Health is sponsoring the European PRRS Research Award to support applied research for improved control of the swine disease PRRS (Porcine Reproductive and Respiratory Syndrome). Research proposals for the 2017 award can be submitted until July 1. Boehringer Ingelheim Animal Health will provide three grants of €25,000 (US$26,648.75) each to fund research proposals that will generate new and relevant data to better understand this devastating and costly disease.

The European PRRS Research Award aims at encouraging research, which eventually results in practical application strategies to control PRRS and enhances the interaction among swine researchers and veterinarians. In addition, Boehringer Ingelheim Animal Health’s intention is to further stimulate communication in the industry on practical PRRS control strategies and to reward research excellence. The PRRS virus infects pigs around the globe causing respiratory tract illness in growing pigs and reproductive failure in breeding stock. Boehringer Ingelheim Animal Health strives to find solutions for sustainable PRRS control.

Applications to submit research proposals should be sent via email to eva.joras@boehringer-ingelheim.com. Further information on the submission process could be found on www.prrs.com.

An independent review board will assess each proposal carefully. Members of the review board are highly recognized swine industry professionals including researchers and practitioners. The board will select proposals based on several factors, including their significance, potential for impact to the swine industry, originality and innovation.

The winners of this year’s European PRRS Research Award will be announced in September 2017.

Comments powered by Disqus